TABLE 1.
Temperature and drug sensitivities of wild-type and mutant strains
| Strain or genotype | Growth
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| YPD
|
Cycloheximide, 0.4 μg/μl | Hygromycin B, 25 μg/μl | Caffeine, 7.5 mM | Formamide, 3% | Rapamycin, 5 μg/μl | Oligomycin, 1.5 μg/μl | |||
| 16°C | 30°C | 37°C | |||||||
| KY898 | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ |
| Δaca1 | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ |
| Δaca2 | − | + | + | − | ± | ++ | − | + | ± |
| Δaca1 Δaca2 | − | + | + | − | ± | ++ | − | + | ± |
| Δacr1 | ++ | ++ | ++ | ++ | ++ | − | + | ++ | ++ |
| Δacr1 Δaca1 | ++ | ++ | ++ | ++ | ++ | + | + | ++ | ++ |
| Δacr1 Δaca2 | − | + | + | − | ± | + | − | + | ± |
| Δacr1 Δaca1 Δaca2 | − | + | + | − | ++ | ++ | − | + | ± |
| 2μm-Aca1 in Δaca2 | ++ | ++ | NDa | ND | ND | ND | ND | ND | ND |
ND, not determined.